Genesis Therapeutics

Home - Genesis Molecular AI

Burlingame, United States · Founded 2019 · $256.1M raised

Headquarters
Burlingame
Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$256.1M
Last Round
$200.0M Series BAug 2023
Rounds
3

About

Genesis Therapeutics uses its proprietary GEMS platform, combining deep learning and molecular simulations, to discover small molecule drugs for challenging disease targets. Backed by over $300M from Andreessen Horowitz, NVIDIA, and Fidelity, the company has established major platform collaborations with Gilead, Genentech, and Incyte.

Summary

Genesis Therapeutics is an Artificial Intelligence company based in Burlingame, United States, founded in 2019. It has raised $256.1M in total across 3 rounds, most recently a $200.0M Series B round in Aug 2023.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BAug 2023
$200.0M

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genesis Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/genesis-therapeutics"><img src="https://indexed.vc/api/badge/company/genesis-therapeutics" alt="Genesis Therapeutics on Indexed.vc" width="260" height="76" /></a>